Thymosin beta 10 and thymosin beta 4 are both actin monomer sequestering proteins.
Level 5 - mechanism / opinion, no new human data
In vitro bench biochemistry study using recombinant proteins
What was done
Thymosin beta 4 and thymosin beta 10 were expressed in bacteria and tested for their interaction with skeletal muscle actin in vitro. The researchers evaluated the solution state of thymosin beta 4 via equilibrium sedimentation, measured binding affinities and inhibition of actin polymerization in the presence or absence of polyphosphoinositides, and analyzed kinetic rates of barbed end filament growth across varying beta-thymosin to actin ratios.
What was found
Equilibrium sedimentation showed that thymosin beta 4 exists as a monomer in solution. Both thymosin beta 4 and beta 10 bound actin and inhibited polymerization with dissociation constants (Kd) between 0.7 and 1 microM, and their activity was not inhibited by polyphosphoinositides. At high ratios of beta-thymosin to actin, the rate of barbed end filament growth decreased, though at lower ratios, the growth rate was slightly larger than expected despite kinetic and steady-state Kd values matching closely.
Why it matters
These findings show that thymosin beta 10 functions alongside thymosin beta 4 as a primary actin monomer sequestering protein rather than functioning like profilin.
Limits
The study was conducted entirely in vitro with purified skeletal muscle actin and recombinant bacterial proteins, which may not capture full cellular complexity or in vivo regulation. Exact kinetic mechanisms underlying the slight deviation in filament growth at lower protein ratios were not fully resolved.
Cited by
- supports Thymosin beta-4 (TB4) fragments interact with actin to help preserve actin in muscle tissue.